Consolidated Balance Sheets (USD $)	Sep. 30, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 3,795,763	$ 2,470,852
Short-term investments	5,000,000	5,360,970
Accounts receivable, net	1,699,889	1,986,125
Income tax receivable	379,036	185,386
Deferred tax assets	1,289,065	0
Prepaid expenses and other current assets	122,082	91,925
Total current assets	12,285,835	10,095,258
Deferred royalty buy-down	1,250,000	1,250,000
Deferred tax assets -long term	1,762,132	0
Patent costs, net	164,027	173,443
Total assets	15,461,994	11,518,701
Current liabilities:
Accounts payable and accrued expenses	732,930	893,083
Accrued third-party development expenses	0	2,649,369
Deferred revenue	437,100	483,769
Accrued liabilities of discontinued operations	78,138	78,138
Total current liabilities	1,248,168	4,104,359
Long-term deferred revenue	385,795	713,619
Stockholders' equity:
Series A Preferred stock, $.50 par value, 700,000 shares authorized; none outstanding	0	0
Common stock, $.001 par value; 10,000,000 shares authorized; 6,530,743 and 6,445,743 shares issued at September 30, 2011 and December 31, 2010, respectively	6,531	6,446
Additional paid-in capital	18,697,136	17,739,765
Accumulated deficit	(3,363,231)	(9,893,530)
Treasury stock, 169,633 and 151,875 shares at cost at September 30, 2011 and December 31, 2010, respectively	(1,512,405)	(1,151,958)
Total stockholders' equity	13,828,031	6,700,723
Total liabilities and stockholders' equity	$ 15,461,994	$ 11,518,701